GBP2 drives glioblastoma invasion via the Stat3/fibronectin pathway, linking immune signaling to extracellular matrix remodeling and physical tumor spread, facilitated by its homodimerization and cytoskeletal interactions [31]. Here, GBP2 is linked to neoplasm.